Educational interventions to improve antibiotic use in the community: Report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002

Lancet Infectious Diseases

Volumn 4, Issue 1, 2004, Pages 44-53

  Finch, Roger G ^a   Metlay, Joshua P ^b   Davey, Peter G ^c   Baker, Lee J ^d  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d Clinical Sciences Building ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BEHAVIOR; COMMUNITY; COST EFFECTIVENESS ANALYSIS; CULTURAL FACTOR; DAY CARE; HAND WASHING; HEALTH EDUCATION; HEALTH PRACTITIONER; INFECTION CONTROL; PALLIATIVE THERAPY; PARENT; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SOCIAL ASPECT;

EID: 0347987049     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(03)00860-0     Document Type: Note

References (60)

1. European Commission. Communication from the Commission on a Community Strategy Against Antimicrobial Resistance [COM (2001) 333 Vol I]. Brussels: Commission of the European Communities, 2001.
2. Interagency Task Force on Antimicrobial Resistance. Public health action plan to combat antimicrobial resistance. Atlanta, GA: Centers for Disease Control and Prevention, 2001.
3. World Health Organization. WHO global strategy for the containment of antimicrobial resistance. Geneva: World Health Organization, 2001.
4. Carbon C, Otto C, Christiansen K. Moving from recommendation to implementation and audit: part 1. Current recommendations and programs: a critical commentary. Clin Microbiol Infect 2002; 8 (suppl 2): 92-106.
5. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory tract infections in the United States. Clin Infect Dis 2001; 33: 757-62.
6. McCaig LF, Besser RE, Hughtes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 2002; 287: 3096-12.
7. Willey C, Laforge R, Blais L, Pallonen U, Prochaska J, Botelho R. Public health and the science of behavior change. Curr Iss Publ Health 1996; 2: 18-25.
8. Elder JP, Ayala GX, Harris S. Theories and intervention approaches to health-behavior change in primary care. Am J Prev Med 1999; 17: 275-84.
9. Pechere LC. Patients' interviews and misuse of antibiotics. Clin Infect Dis 2001; 33 (suppl 3): 170-73.
10. Belongia EA, Naimi TS, Gale CM, Besser RE. Antibiotic use and upper respiratory infections: a survey of knowledge, attitudes, and experience in Wisconsin and Minnesota. Prevent Med 2002; 34: 346-52.
11. Kuzujanakis M, Klienman, K, Rifas-Shiman S, Finkelstein JA. Correlates of parental antibiotic knowledge, demand, and reported use. Ambul Pediatr 2003; 3: 203-10.
12. Prochaska JO, DiClemente CC. Stages of change in the modification of problem behaviors. In: Hersen M, Eisler RM, Miller PM, eds. Progress in behavior modification (vol 28). Terre Haute, IN: Sycamore, 1992. 184-218.
13. Rotter JB. The development and applications of social learning theory. New York: Praeger, 1982.
14. Strecher VJ, DeVellis BM, Becker MH, Rosenstock IM. The role of self-efficacy in achieving health behavior change. Health Educ Q 1986; 13: 73-92.
15. Weiner B. An attributional theory of motivation and emotion. New York: Springer-Verlag, 1986.
16. Ajzen I. Attitudes, personality and behavior. Chicago, IL: Dorsey Press, 1988.
17. Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the health belief model. Health Educ Q 1988; 15: 175-83.
18. Green LW, Kreuter MW. Health promotion planning: an educational and environmental approach, 2nd edn. Mountain View, CA: Mayfield Publishing Company, 1991.
19. Mullen, PD, Hersey JC, Iverson DC. Health behavior models compared. Soc Sci Med 1987; 24: 973-81.
20. Davis DA, Thomson MA, Oxman AD, Haynes RB. Evidence for the effectiveness of CME. A review of 50 randomized controlled trials. JAMA 1992; 268: 1111-117.
21. Cleemput I, Kestelroot K. Economic implications of non-compliance in health care. Lancet 2002; 359: 2129-30.
22. Davey P, Pagliari C, Hayes A. The patient's role in the spread and control of bacterial resistance. Clin Microbiol Infect 2002; 8 (suppl 2): 43-68.
23. Mangione-Smith R, McGlynn EA, Elliott MN, McDonald L, Franz CE, Kravitz RL. Parent expectations for antibiotics, physician-parent communication, and satisfaction. Arch Pediatr Adolesc Med 2001; 155: 800-06.
24. Mangione-Smith R, McGlynn EA, Krogstad P, Brook RH. The relationship between perceived parental expectations for antibiotics and pediatrician antimicrobial prescribing behavior. Pediatrics 1999; 103: 711-18.
25. Wheeler JG, Fair M, Simpson PM, Rowlands LA, Aitken ME, Jacobs RF. Impact of a waiting room videotape message on parent attitudes toward pediatric antibiotic use. Pediatrics 2001; 108: 591-96.
26. Pechere JC, Cenedese C, Muller O, et al. Attitudinal classification of patients receiving antibiotic treatment for mild respiratory tract infections. Int J Antimicrob Agents 2002; 20: 399-406.
27. Blondel-Hill E, Fryters S, Mitchell S, Tomney M, Wilson D, Carson M. Do Bugs Need Drugs? A community project for the wise use of antibiotics [Abstract L-2064]. In: Abstracts of the 41st Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; December 16-19 2001; Chicago (IL), USA. Washington, DC: American Society for Microbiology, 2001: 476.
28. Lipsitch M. Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae. Clin Infect Dis 2001; 32: 1044-54.
29. Metlay JP, Singer DE. Outcomes in lower respiratory tract infections and the impact of antimicrobial drug resistance. Clin Microbiol Infect 2002; 8 (suppl 2): 1-11.
30. McIsaac WJ, Goel V, To T, Low DE. The validity of a sore throat score in family practice. Can Med Assoc J 2000; 163: 811-15.
31. Cars O, Mokstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357: 1851-53.
32. de Melker RA, Kuyvenhoven MM. Management of upper respiratory tract infections in Dutch family practice. J Fam Pract 1994; 38: 353-57.
33. Lee MB. Frequency of handwashing and protection of health. Can J Infect Control 2000 Fall; 19: 89-91.
34. Ryan MA, Christian RS, Wohlrabe J. Handwashing and respiratory illness among young adults in military training. Am J Prev Med 2001; 21: 79-83.
35. Finch RG, Low DE. A critical assessment of published guidelines and other decision-support systems for the antibiotic treatment of community-acquired respiratory tract infections. Clin Microbiol Infect 2002; 8 (suppl 2): 69-91.
36. Ball P, Baquero F, Cars O, et al. Antibiotic therapy of community-acquired respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J Antimicrob Chemother 2002; 49: 31-40.
37. Finkelstein JA, Davis RL, Dowell S, et al. Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics 2001; 108: 1-7.
38. Thompson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Educational outreach visits: effects on professional practice and health care outcomes (Cochrane Review). In: The Cochrane Library. Issue 3. Oxford: Update Software, 2001.
39. Food and Drugs Administration. Labeling requirements for systemic antibacterial drug products intended for human use. Document 21CFR Part 201. Rockville, MD: Food and Drugs Administration, 2003.
40. Hutchinson L. Evaluating and researching the effectiveness of educational interventions. BMJ 1999; 318: 1267-69.
41. Belongia EA, Sullivan BJ, Chyou P-H, Madagame E, Reed KD, Schwartz B. A community intervention trial to promote judicious antibiotic use and reduce penicillin-resistant Streptococcus pneumoniae carriage in children. Pediatrics 2001; 108: 575-83.
42. Hennessy TW, Petersen KM, Bruden D, et al. Changes in antibiotic-prescribing practices and carriage of penicillin-resistant Streptococcus pneumoniae: a controlled intervention trial in rural Alaska. Clin Infect Dis 2002; 34: 1543-50.
43. Green J, Britten N. Qualititative research and evidence based medicine. BMJ 1998; 16: 1230-32.
44. Kirkpatrick DI. Evaluation of training. In Craig R, Bittel I, eds. Training and development handbook. New York: McGraw-Hill, 1967.
45. Carson, M, Wilson D, Senthilselvan A, Franchuk C, Blondel-Hill E. Do Bugs Need Drugs? Daycare Project [Abstract G-1480]. In: Abstracts of the 42nd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; San Diego; 2002 Sep 27-30; Washington, DC: American Society for Microbiology, 2002: 256.
46. Bauraind I, Goossens H, Hendrickx E, et al. Two years of national public campaigns to promote appropriate use of antibiotics in the community in Belgium [Abstract A-1362]. In Abstracts of the 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; Chicago, IL; 2003 Sept 14-17. Washington, DC: American Society for Microbiology, 2003: 26.
47. Christiansen K, Carbon C, Cars O. Moving from recommendation to implementation and audit: Part 2. Intervention and audit. Clin Microbiol Infect 2002; 8 (suppl 2): 107-28.
48. Gonzales R, Steiner IF, Lum A, Barrett P. Decreasing antibiotic use in ambulatory practice. Impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 1999; 281: 1512-19.
49. Perz JF, Craig AS, Coffey CS, et al. Changes in antibiotic prescribing for children after a community-wide campaign. JAMA 2002; 287: 3103-09.
50. Seppälä H, Klaukka T, Lehtonen R, Neonen E, Huovinen P. Outpatient use of erythromycin: link to increased erythromycin resistance in Group A streptococci. Clin Infect Dis 1995; 21: 1378-85.
51. Granizo JJ, Aguilar L, Casal J, Garcia-Rey C, Dal-Re R, Baquero F. Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997). J Antimicrob Chemother 2000; 46: 767-73.
52. Granizo JJ, Aguilar L, Casal J, Dal-Re R, Baquero F. Streptococcus pyogenes resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997). J Antimicrob Chemother 2000; 46: 959-64.
53. Garcia-Rey C, Aguilar L, Baquero F, Casal J, Dal-Re R. Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. J Clin Microbiol 2002; 40: 159-64.
54. Guillemot D, Henriet L, Lecoeur H, Weber P, Carbon C. Optimization of antibiotic use rapidly decreases penicillin resistant Streprococcus pneumoniae (PRSp) carriage: the AUBEPPIN Study [Abstract 1527]. In: Abstracts of the 41st Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; 2001 December 16-19; Chicago, IL, USA. Washington, DC: American Society for Microbiology, 2001: 264.
55. Felmingham D, Feldman C, Hryniewicz W, et al. Surveillance of bacterial resistance in community-acquired respiratory tract infections. Clin Microbiol Infect 2002; 8 (suppl 2): 12-42.
56. Vilhelmsson SE, Tomasz A, Kristinsson KG. Molecular evolution in a multidrug-resistant lineage of Streptococcus pneumoniae: emergence of strains belonging to the serotype 6B Icelandic clone that lost antibiotic resistance traits. J Clin Microbiol 2000; 38: 1375-81.
57. Bronzwaer SL, Cars O, Buchholz U, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 8: 278-82.
58. Steinke D, Davey PG. The association between antibiotic resistance and community prescribing: a critical review of bias and confounding in published studies. Clin Infect Dis 2001; 33 (suppl 3): S193-205.
59. Harbarth S, Harris AD, Carmeli Y, Samore MH. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Clin Infect Dis 2001; 33: 1462-68.
60. Hall AJ. Ecological studies and debate on rotavirus vaccine and intussusception. Lancet 2001; 358: 1197-98.